Estradiol-3-Benzoate-17-Butyrate | Hormone Intermediate | Pharmaceutical Grade API
■■■■■■■■■■■■■■■■■■■■
Product Overview
Estradiol-3-Benzoate-17-Butyrate is a high-purity steroid derivative used as a key intermediate in synthesizing advanced hormone therapies and oncology APIs14. Its dual ester structure enhances bioavailability and stability, making it ideal for long-acting contraceptive formulations, estrogen replacement drugs, and targeted cancer treatments25.
Key Advantages
✔ >99.5% HPLC-Verified Purity: Rigorous quality control ensures compliance with USP/EP pharmacopeia standards23.
✔ Extended Half-Life: Optimized pharmacokinetics for sustained-release formulations (T½ >72 hours)34.
✔ GMP-Certified Production: Full traceability from raw materials to final packaging24.
Applications
◈ Hormone Replacement Therapies: Menopause management and osteoporosis prevention14.
◈ Oncology Drug Development: Estrogen receptor modulators for breast and prostate cancer35.
◈ Veterinary Pharmaceuticals: Fertility regulation in livestock and companion animals34.
Quality Certifications
■ USP <467> Compliance: Residual solvents (methanol, ethyl acetate) below 50 ppm24.
■ Stability-Tested: 36-month shelf life under 15-25°C storage with light protection23.
Market Trends
The global hormone therapy market is projected to reach $35.2 billion by 2030, driven by aging populations and rising oncology R&D investments45. Estradiol derivatives dominate 22% of the contraceptive API segment, with CAGR of 8.3% in oncology applications34.
■■■■■■■■■■■■■■■■■■■■
High-Value Keywords:
Hormone Therapy Intermediate
Pharmaceutical Grade API Synthesis
USP-Compliant Steroid Derivative
Long-Acting Contraceptive Precursor
Oncology Drug Development
Google Search Optimized Terms:
GMP-Certified Hormone Intermediate
High-Purity Estradiol Derivative
Stability-Tested Oncology API
USP/EP Pharmaceutical Compliance
Veterinary Fertility Regulation
China
